These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8743062)

  • 61. Development of a videotape on adverse drug reactions.
    Morgan SA; Frank JT
    Am J Hosp Pharm; 1990 Jun; 47(6):1340-2. PubMed ID: 1695062
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh.
    Amin MN; Khan TM; Dewan SM; Islam MS; Moghal MR; Ming LC
    BMJ Open; 2016 Aug; 6(8):e010912. PubMed ID: 27489151
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An observational study to compare the contents and quality of information furnished in CDSCO ADR reporting form, yellow card, medwatch and blue form by the healthcare professionals.
    Rehan HS; Chopra D; Holani SN; Mishra R
    Int J Risk Saf Med; 2014; 26(1):1-8. PubMed ID: 24796346
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Experience with an adverse drug reaction reporting program in a neurology specialty clinic.
    Ryan M; Gora-Harper ML; Caldwell F
    Ann Pharmacother; 2002 Feb; 36(2):231-5. PubMed ID: 11847939
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Avoidance of Adverse Drug Reactions by Pharmacists (Through the PreAVOID Report)].
    Tanigawa K
    Rinsho Byori; 2016 Sep; 64(9):1082-1084. PubMed ID: 30609463
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A description of a successful computerized adverse drug reaction tracking program.
    Maliekal J; Thornton J
    Hosp Formul; 1990 Apr; 25(4):436-9, 442. PubMed ID: 10104234
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
    Ball D; Tisócki T
    Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adverse drug reaction monitoring in a secondary care hospital in South India.
    Arulmani R; Rajendran SD; Suresh B
    Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Developing an adverse drug reaction reporting system at a teaching hospital.
    Baniasadi S; Fahimi F; Shalviri G
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):408-11. PubMed ID: 18312492
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmaceutical services in U.S. hospitals in 1989.
    Raehl CL; Bond CA; Pitterle ME
    Am J Hosp Pharm; 1992 Feb; 49(2):323-46. PubMed ID: 1553999
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adverse drug reactions in an elderly outpatient population.
    Schneider JK; Mion LC; Frengley JD
    Am J Hosp Pharm; 1992 Jan; 49(1):90-6. PubMed ID: 1570873
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs.
    Jarernsiripornkul N; Kakaew W; Loalukkana W; Krska J
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):240-5. PubMed ID: 19148880
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.
    Vallano A; Cereza G; Pedròs C; Agustí A; Danés I; Aguilera C; Arnau JM
    Br J Clin Pharmacol; 2005 Dec; 60(6):653-8. PubMed ID: 16305591
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Drug safety reports on complementary and alternative medicines (ayurvedic and homeopathic medicines) by a spontaneous reporting program in a tertiary care hospital.
    Jose J; Rao PG; Kamath MS; Jimmy B
    J Altern Complement Med; 2009 Jul; 15(7):793-7. PubMed ID: 19534607
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A survey of adverse drug reaction reporting programs in select hospitals.
    Case RL; Guzzetti PJ
    Hosp Pharm; 1986 May; 21(5):423-6, 431-4, 438. PubMed ID: 10276799
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An educational intervention to improve nurses' knowledge, attitude, and practice toward reporting of adverse drug reactions.
    Hanafi S; Torkamandi H; Hayatshahi A; Gholami K; Shahmirzadi NA; Javadi MR
    Iran J Nurs Midwifery Res; 2014 Jan; 19(1):101-6. PubMed ID: 24554968
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of a Policy Change on Pharmacists' Reporting of Adverse Drug Reactions.
    Roy R; Ma J
    Can J Hosp Pharm; 2018; 71(4):227-233. PubMed ID: 30185996
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adverse drug reaction surveillance and risk management.
    Johnston PE
    Perspect Healthc Risk Manage; 1992; 12(2):22-4. PubMed ID: 10116674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.